IL85472A - Pharmaceutical compositions for treating gastrointestinal disorders - Google Patents

Pharmaceutical compositions for treating gastrointestinal disorders

Info

Publication number
IL85472A
IL85472A IL85472A IL8547288A IL85472A IL 85472 A IL85472 A IL 85472A IL 85472 A IL85472 A IL 85472A IL 8547288 A IL8547288 A IL 8547288A IL 85472 A IL85472 A IL 85472A
Authority
IL
Israel
Prior art keywords
gastrointestinal disorders
pharmaceutical compositions
treating gastrointestinal
treating
agent
Prior art date
Application number
IL85472A
Other languages
English (en)
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21816098&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL85472(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of IL85472A publication Critical patent/IL85472A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/345—Nitrofurans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL85472A 1987-03-09 1988-02-19 Pharmaceutical compositions for treating gastrointestinal disorders IL85472A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2359687A 1987-03-09 1987-03-09

Publications (1)

Publication Number Publication Date
IL85472A true IL85472A (en) 1991-06-30

Family

ID=21816098

Family Applications (1)

Application Number Title Priority Date Filing Date
IL85472A IL85472A (en) 1987-03-09 1988-02-19 Pharmaceutical compositions for treating gastrointestinal disorders

Country Status (13)

Country Link
US (1) US5407688A (de)
EP (2) EP0578965A1 (de)
JP (1) JP2648328B2 (de)
KR (1) KR970007188B1 (de)
AT (1) ATE117206T1 (de)
AU (2) AU621285B2 (de)
CA (1) CA1312012C (de)
DE (1) DE3852773T2 (de)
DK (1) DK175866B1 (de)
IE (2) IE950632L (de)
IL (1) IL85472A (de)
NZ (1) NZ223774A (de)
ZA (1) ZA881678B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL85472A (en) * 1987-03-09 1991-06-30 Procter & Gamble Pharmaceutical compositions for treating gastrointestinal disorders
EP0282132B1 (de) * 1987-03-09 1992-09-30 The Procter & Gamble Company Zusammensetzungen und ihre Verwendung zur Behandlung von Magen-Darmstörungen
CH679582A5 (de) * 1988-07-18 1992-03-13 Glaxo Group Ltd
AU641903B2 (en) * 1988-10-26 1993-10-07 Glaxo Group Limited Carboxylic acid derivatives
EP0403048A3 (de) * 1989-06-14 1991-01-30 Warner-Lambert Company Medizinische Sucralfat enthaltende Zusammensetzungen und Verfahren zur Herstellung
GB9010039D0 (en) * 1990-05-03 1990-06-27 Reckitt & Colmann Prod Ltd Medicament preparation
ATE135227T1 (de) * 1990-07-20 1996-03-15 Slagel David Produkte und verfahren zur behandlung des verdauungskanals
GB9018603D0 (en) * 1990-08-24 1990-10-10 Smith Kline French Lab Compositions
ATE209914T1 (de) * 1990-09-14 2001-12-15 Byk Gulden Lomberg Chem Fab Verwendung von pyridylmethylsulfinyl-1h- benzimidazol derivaten zur behandlung durch helicobacter verursachter erkrankungen
US5192752A (en) * 1991-01-14 1993-03-09 The Procter & Gamble Company Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate
GB9120131D0 (en) * 1991-09-20 1991-11-06 Glaxo Group Ltd Medicaments
DK0550083T3 (da) * 1991-12-06 1999-10-11 Glaxo Group Ltd Lægemidler til behandling af inflammatoriske tilstande eller til analgesi og indeholdende et NSAID og ranitidinbismuthcitra
GB9127150D0 (en) * 1991-12-20 1992-02-19 Smithkline Beecham Plc Novel treatment
IS3990A (is) * 1992-04-24 1993-10-25 Ab Astra Aðferð við að blanda saman efni sem hindrar flæðimagasýru og bakteríueyðandi efnis sem brotnar niður í súru umhverfi
AU6436394A (en) * 1993-06-15 1995-01-03 Pfizer Inc. H2-antagonists as immune stimulants in bacterial infections of cattle or swine
WO1996014068A1 (de) * 1994-11-07 1996-05-17 Asche Ag Arzneimittel zur behandlung von erkrankungen des magen-darm-traktes
US5861518A (en) * 1994-11-21 1999-01-19 Dekker; Koenraad A. Phthalide compounds and their production process
JP3767831B2 (ja) * 1995-06-14 2006-04-19 木村 健 ヘリコバクター・ピロリ除菌用組成物
JP2001526625A (ja) * 1995-11-13 2001-12-18 オールバニ メジカル カレッジ 鎮痛性化合物およびその使用
US5744168A (en) * 1995-12-07 1998-04-28 The Procter & Gamble Company Methods and compositions for the prevention and treatment of gastrointestinal disorders
JP2002529503A (ja) 1998-11-17 2002-09-10 ニトロメッド，インク． ニトロソ化及びニトロシル化ｈ２リセプターアンタゴニスト化合物及び組成物並びにその利用方法
PE20050150A1 (es) 2003-05-08 2005-03-22 Altana Pharma Ag Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo
CL2004000983A1 (es) 2003-05-08 2005-03-04 Altana Pharma Ag Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
WO2005107721A2 (en) 2004-05-07 2005-11-17 Altana Pharma Ag Pharmaceutical dosage form comprising pellets as well as its manufacturing process
CA2677399C (en) * 2007-02-09 2016-09-13 Tranzyme Pharma, Inc. Macrocyclic ghrelin receptor modulators and methods of using the same
JP2011178722A (ja) * 2010-03-01 2011-09-15 Synmosa Biopharma Corp ヘリコバクタ−・ピロリ（Ｈ．ｐｙｌｏｒｉ）を除菌する医薬組成物及びその製造方法
EP2601947A1 (de) * 2011-12-05 2013-06-12 Abo Bakr Mohammed Ali Al-Mehdar Kombinationspräparat mit fester Dosierung zur Behandlung von Erkrankungen einhergehend mit Helicobacter pylori

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2218883B1 (de) * 1973-02-28 1976-08-13 Science Union & Cie
US4333922A (en) * 1974-09-12 1982-06-08 Herschler R J Method for the treatment of water-living animals with health modifying agents
CH638975A5 (fr) * 1979-07-27 1983-10-31 Prebuilt Ets Composition medicamenteuse pour le traitement des ulceres gastro-duodenaux.
EP0222834A4 (de) * 1985-04-18 1989-10-04 Borody Thomas J Behandlung von nichtulcerativer dyspepsia mit wismutsalzen.
EP0206625B1 (de) * 1985-06-13 1992-09-30 Barry James Dr. Marshall Zusammensetzungen zur Behandlung von Magen-Darmstörungen
DE3686362T2 (de) * 1985-06-13 1993-02-11 Marshall Barry James Verfahren zur behandlung von magen-darmstoerungen.
US4959384A (en) * 1985-10-24 1990-09-25 Norwich Eaton Pharmaceuticals, Inc. Use of nitrofurantoin for the treatment and prophylaxis of gastrointestinal disorders
IL85472A (en) * 1987-03-09 1991-06-30 Procter & Gamble Pharmaceutical compositions for treating gastrointestinal disorders
EP0282132B1 (de) * 1987-03-09 1992-09-30 The Procter & Gamble Company Zusammensetzungen und ihre Verwendung zur Behandlung von Magen-Darmstörungen
CH679582A5 (de) * 1988-07-18 1992-03-13 Glaxo Group Ltd
DE3830616A1 (de) * 1988-09-09 1990-03-15 Ruetgerswerke Ag Prophylaktikum fuer fische

Also Published As

Publication number Publication date
KR970007188B1 (ko) 1997-05-07
JP2648328B2 (ja) 1997-08-27
EP0578965A1 (de) 1994-01-19
DK127788A (da) 1988-09-10
NZ223774A (en) 1991-02-26
US5407688A (en) 1995-04-18
ATE117206T1 (de) 1995-02-15
DE3852773D1 (de) 1995-03-02
EP0282131B1 (de) 1995-01-18
CA1312012C (en) 1992-12-29
IE66367B1 (en) 1995-12-27
AU1279388A (en) 1988-09-08
JPS63290831A (ja) 1988-11-28
EP0282131A3 (en) 1989-11-15
AU1030292A (en) 1992-03-05
DK127788D0 (da) 1988-03-09
DK175866B1 (da) 2005-04-18
AU660645B2 (en) 1995-07-06
IE880665L (en) 1988-09-09
AU621285B2 (en) 1992-03-12
EP0282131A2 (de) 1988-09-14
KR880011197A (ko) 1988-10-27
DE3852773T2 (de) 1995-07-06
IE950632L (en) 1988-09-09
ZA881678B (en) 1988-09-07

Similar Documents

Publication Publication Date Title
EP0282131A3 (en) Compositions and methods for treating gastrointestinal disorders
EP0282132A3 (en) Compositions and methods for treating gastrointestinal disorders
ATE90082T1 (de) Imidazol-verbindung und diese enthaltende biozide zusammensetzungen.
HU9501053D0 (en) Ranitidine chewable tablets
CA2158475A1 (en) Composition and method for reducing toxicity of biologically-active factors
CA2108455A1 (en) Pharmaceutical compositions against gastric disorders
ZA923179B (en) Herbicidal compositions with increased crop safety
DK465488D0 (da) Farmaceutisk praeparat indeholdende en triazol-forbindelse
IT8022850A0 (it) Copolimeri ad attivita'battericida, procedimento per laloro preparazione e relative composizioni farmaceutiche.
HUT58467A (en) Treatment of concrete roofing elements with microbiocidal agent
IL117655A (en) Phamaceutical composition comprising a supported saccharide for the treatment of travellers' diarrhea caused by enterotoxigenic E.coli
CY2167B1 (en) Pharmaceutical compositions containing 5-difluoromethoxy-2- (3,4-dimethoxy-2-pyridyl) methylsulfinylue benzimidazole and an anti-helicobacter agent f or the treatment of gastrointestinal disorders
IT8421241A0 (it) Composti ad attivita'antibatterica, procedimento per laloro preparazione e relative composizioni farmaceutiche.
IL89392A (en) Compositions for the treatment of osteoporosis in humans comprising 24, 25-dihydroxy-vitamin d3
EP0155934A4 (de) Pharmazeutische Zusammensetzungen zur Behandlung von Störungen, bedingt durch Humanendrogen.
ES267504Y (es) "herraje de inversion para el cinturon de seguridad".
IL91152A0 (en) Furylthiazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
NZ226968A (en) 1-phenylpropane-dione derivatives and ectoparasiticidal compositions
IL92817A0 (en) Substituted guanidine and amidine compounds,their production and fungicidal compositions containing same
NZ229627A (en) Diorganotin compounds, and bactericidal and fungicidal compositions containing them
IE880313L (en) Fungicidal compositions
ATE21009T1 (de) Lagerstabile, die wirkstoffe pyrazophos und captafol enthaltende, mittel.
ZA923180B (en) Herbicidal compositions with increased crop safety
IL124730A (en) Compositions for the treatment of gastrointestinal disorders comprising a bismuth compound and one or more antimicrobials, and the use of bismuth and an antimicrobial compound for the preparation of such compositions
IT8719184A0 (it) Gastroduodenale. composizioni farmaceutiche ad azione sinergica antisecretoria per la cicatrizzazione dell'ulcera

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
EXP Patent expired